G
Grazia Bossi
Researcher at University of Pavia
Publications - 59
Citations - 1284
Grazia Bossi is an academic researcher from University of Pavia. The author has contributed to research in topics: Medicine & Langerhans cell histiocytosis. The author has an hindex of 19, co-authored 53 publications receiving 1131 citations.
Papers
More filters
Journal ArticleDOI
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children
Marco Gattorno,Maria Pia Sormani,Andrea D'Osualdo,MA Pelagatti,Francesco Caroli,Silvia Federici,Massimiliano Cecconi,Nicoletta Solari,Antonella Meini,Francesco Zulian,Laura Obici,Luciana Breda,Silvana Martino,Alberto Tommasini,Grazia Bossi,A. Govers,A. Govers,Isabelle Touitou,P Woo,J. Frenkel,J. Frenkel,Isabelle Koné-Paut,Maurizia Baldi,Isabella Ceccherini,Alberto Martini +24 more
TL;DR: The proposed approach in patients with periodic fever will increase the probability of obtaining positive results on genetic testing, with good specificity and sensitivity, and help to optimize the molecular analysis by suggesting the order in which the genes should be screened.
Journal ArticleDOI
Clinical features and follow-up in patients with 22q11.2 deletion syndrome.
Caterina Cancrini,Pamela Puliafito,Maria Cristina Digilio,Annarosa Soresina,Silvana Martino,Roberto Rondelli,Rita Consolini,E Ruga,Fabio Cardinale,Andrea Finocchi,Maria Luisa Romiti,Baldassarre Martire,Rosa Bacchetta,V. Albano,Adriano Carotti,Fernando Specchia,Davide Montin,Emilia Cirillo,Guido Cocchi,Antonino Trizzino,Grazia Bossi,Ornella Milanesi,Chiara Azzari,Giovanni Corsello,Claudio Pignata,Alessandro Aiuti,Alessandro Aiuti,Maria Cristina Pietrogrande,Bruno Marino,A G Ugazio,Alessandro Plebani,Paolo Rossi +31 more
TL;DR: In this paper, the authors investigated the clinical manifestations at diagnosis and during follow-up in patients with 22q11.2 deletion syndrome to better define the natural history of the disease and provided guidelines for pediatricians and specialists for early identification of cases that can be confirmed by genetic testing, which would permit the provision of appropriate clinical management.
Journal ArticleDOI
Long-Term Clinical Profile of Children With the Low-Penetrance R92Q Mutation of the TNFRSF1A Gene
MA Pelagatti,Antonella Meini,Roberta Caorsi,Marco Cattalini,Silvia Federici,Francesco Zulian,G Calcagno,Alberto Tommasini,Grazia Bossi,Maria Pia Sormani,Francesco Caroli,Alessandro Plebani,Isabella Ceccherini,Alberto Martini,Marco Gattorno +14 more
TL;DR: The frequency of typical TRAPS-related clinical manifestations was significantly lower and the impact of the disease on HRQOL was significantly reduced in patients with the R92Q mutation compared with TRAPS patients carrying structural mutations of TNFRSF1A.
Journal ArticleDOI
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase
Alessandra Marchesi,Isabella Tarissi de Jacobis,Donato Rigante,Alessandro Rimini,Walter Malorni,Giovanni Corsello,Grazia Bossi,Sabrina Buonuomo,Fabio Cardinale,Elisabetta Cortis,Fabrizio De Benedetti,Andrea Zorzi,Marzia Duse,Domenico Del Principe,Rosa Maria Dellepiane,Livio D’Isanto,Maya El Hachem,Susanna Esposito,Fernanda Falcini,Ugo Giordano,Maria Cristina Maggio,Savina Mannarino,Gian Luigi Marseglia,Silvana Martino,Giulia Marucci,Rossella Massaro,Christian Pescosolido,Donatella Pietraforte,Maria Cristina Pietrogrande,Patrizia Salice,Aurelio Secinaro,Elisabetta Straface,Alberto Villani +32 more
TL;DR: These practical guidelines related to Kawasaki disease are aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD.
Journal ArticleDOI
A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network.
Viviana Moschese,Simona Graziani,M.A. Avanzini,Rita Carsetti,M. Marconi,M La Rocca,Loredana Chini,Claudio Pignata,A Soresina,Rita Consolini,Grazia Bossi,A Trizzino,Silvana Martino,Fabio Cardinale,P Bertolini,Gian Luigi Marseglia,Marco Zecca,S Di Cesare,Isabella Quinti,Roberto Rondelli,Maria Cristina Pietrogrande,Plinio Rossi,Alessandro Plebani +22 more
TL;DR: It is concluded that most patients with an initial diagnosis of THI spontaneously recover within 24 months of age and have a benign clinical course, while a subgroup of children with undefined hypogammaglobulinemia share a clinical and immunological profile with other primary immunodeficiencies.